Financials
- Market Capitalization 158.99 M
- Employee 193
- Founded 2011
- CEO N/A
- Website www.adctherapeutics.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3764 | TLSA Tiziana Life Sciences Ltd - Common Shares | 1.33 USD | +8.13% | +14.66% | +14.66% | -8.90% | 160.27 M USD | ||
| 3770 | MIST Milestone Pharmaceuticals Inc. - Common Shares | 1.28 USD | 0.00% | -1.54% | -1.54% | -9.86% | 159.36 M USD | ||
| 3793 | PYXS Pyxis Oncology, Inc. - Common Stock | 2.44 USD | -8.61% | -1.21% | +37.85% | +108.55% | 154.59 M USD | ||
| 3802 | HUMA Humacyte, Inc. - Common Stock | 0.69 USD | 0.00% | -9.21% | -36.11% | -72.06% | 153.19 M USD |
Frequently asked questions about ADC Therapeutics SA Common Shares
What is the ADC Therapeutics SA Common Shares stock price today?
The current price of ADC Therapeutics SA Common Shares (ADCT) is 1.25. Over the past 24 hours, the stock has changed by -3.10%. Follow the ADCT chart for real-time price dynamics.
What is the stock ticker of ADC Therapeutics SA Common Shares?
ADC Therapeutics SA Common Shares trades under the ticker ADCT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ADC Therapeutics SA Common Shares stock going up?
ADCT has changed by +1.63% over the last week, +15.74% over the last month, and -62.69% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was ADC Therapeutics SA Common Shares net income for the last quarter?
ADC Therapeutics SA Common Shares reported net income of -32.97 M for the last quarter. The previous quarter showed -6.41 M, which means net income changed by -414.40%.
How many employees does ADC Therapeutics SA Common Shares have?
As of the latest available data, ADC Therapeutics SA Common Shares has 193 employees. Workforce size can provide additional context about the company's scale and operations.
What is ADC Therapeutics SA Common Shares EBITDA?
ADC Therapeutics SA Common Shares EBITDA is -18.18 M, and its EBITDA margin is -87.19%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy ADC Therapeutics SA Common Shares stock?
You can buy ADC Therapeutics SA Common Shares (ADCT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ADC Therapeutics SA Common Shares stock?
Investing in ADC Therapeutics SA Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ADCT chart and related analysis on metatrader.com as part of your research.